Mometasone Sandoz nasal spray is indicated for use in adults, adolescents and children 2 years of age and older to treat the symptoms of seasonal allergic or perennial allergic rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Mometasone Sandoz nasal spray may be initiated 2 to 4 weeks prior to the anticipated start of the pollen season.
Mometasone Sandoz nasal spray is indicated for the relief of nasal congestion associated with seasonal allergic rhinitis, in adults and pediatric patients 2 years of age and older.
Mometasone Sandoz nasal spray is indicated for the symptomatic treatment of nasal polyps in adults 18 years of age and older.
Mometasone Sandoz nasal spray is also indicated for use in adults and adolescents 12 years of age and older as adjunctive treatment to antibiotics for acute episodes of sinusitis.
Mometasone Sandoz is also indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of bacterial infection.
Other Services
Country
Account